关于江苏立华食品集团股份有限公司 2024 年度募集资金存放与实际使用情况 鉴证报告 致同会计师事务所（特殊普通合伙） 目 录 致同会计师事务所（特殊普通合伙） 中国北京 朝阳区建国门外大街 22 号 赛特广场 5 层 邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 关于江苏立华食品集团股份有限公司 2024 年度募集资金存放与实际使用情况 鉴证报告 致同专字（2025）第 110A009012 号 江苏立华食品集团股份有限公司全体股东： 关于江苏立华食品集团股份有限公司 2024 年度募集资金 存放与实际使用情况鉴证报告 江苏立华食品集团股份有限公司 2024 年度募集资金 存放与实际使用情况的专项报告 1-5 中国·北京 二〇二五年四月二十一日 我们接受委托，对后附的江苏立华食品集团股份有限公司（以下简称 "立华股份公司"）《2024 年度募集资金存放与实际使用情况的专项报告》 （以下简称 "专项报告"）执行了合理保证的鉴证业务。 按照《上市公司监管指引第 2号——上市公司募集资金管理和使用的监管 要求（2022 ...

江苏立华食品集团股份有限公司 二Ｏ二四年度 内部控制审计报告 二、注册会计师的责任 致同会计师事务所（特殊普通合伙） 致同会计师事务所（特殊普通合伙） 中国北京 朝阳区建国门外大街 22 号 赛特广场 5 层 邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 内部控制审计报告 致同审字（2025）第 110A014761 号 江苏立华食品集团股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求， 我们审计了江苏立华食品集团股份有限公司（以下简称立华股份公司）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内 部控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是 立华股份公司董事会的责任。 中国·北京 二Ｏ二五年四月二十一日 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发 表审计意见，并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有 ...

中泰证券股份有限公司 关于江苏立华食品集团股份有限公司 2024 年度内部控制评价报告的核查意见 中泰证券股份有限公司（以下简称"中泰证券"、"保荐机构"）作为江苏立 华食品集团股份有限公司（以下简称"立华股份"、"公司"）2021 年度创业板 向特定对象发行股票的保荐机构，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》《深圳证券交易所上市公司自律监管指引第 2 号——创业板 上市公司规范运作》等有关法律法规和规范性文件的要求，对立华股份《2024 年 度内部控制评价报告》进行了核查，具体情况如下： 一、保荐机构对公司 2024 年度内部控制评价报告的核查情况 根据公司财务报告内部控制重大缺陷的认定情况，于内部控制评价报告基准 日，不存在财务报告内部控制重大缺陷。董事会认为，公司已按照企业内部控制 规范体系和相关规定的要求在所有重大方面保持了有效的财务报告内部控制。 根据公司非财务报告内部控制重大缺陷认定情况，于内部控制评价报告基准 日，公司未发现非财务报告内部控制重大缺陷。 自内部控制评价报告基准日至内部控制评价报告发 ...

北京市中伦律师事务所 关于江苏立华食品集团股份有限公司 2024 年限制性股票激励计划授予价格调整、预留部 分授予相关事项的 法律意见书 二〇二五年四月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty | 一、本次调整及预留授予的批准与授权 4 | | --- | | 二、本次调整的具体情况 6 | | 三、本次预留授予的具体情况 7 | | 四、结论意见 9 | 北京市中伦律师事务所 关于江苏立华食品集团股份有限公司 2024 年限制性股票激励计划授予价格调整、预留部分授予 相关事项的法律意见书 致 ...

2024 年度独立董事述职报告 各位股东及股东代表： 本人徐联义作为江苏立华食品集团股份有限公司（以下简称公司或本公 司）的独立董事，在任职期间严格按照《中华人民共和国公司法》《上市公司 独立董事管理办法》和《深圳证券交易所创业板股票上市规则》等法律、法规 以及《公司章程》《独立董事制度》等规定，积极参加公司历次董事会、股东 会，充分发挥独立董事的作用，切实维护公司和股东尤其是中小股东的利益。 现将 2024 年度履职情况报告如下： 江苏立华食品集团股份有限公司 一、独立董事基本情况 本人徐联义，1972 年出生，中国国籍，无境外永久居留权，中央财经大学 学士，注册会计师。曾任普华永道中天会计师事务所审计经理，高级经理、阳 光 100 中国控股有限公司 CFO、华夏幸福基业股份有限公司产业小镇集团副总 裁，现任尤尼泰（北京）税务师事务所涉税服务合伙人、北京中启恒会计师事 务所有限责任公司审计合伙人。目前兼任淘珠公咨询（北京）有限公司执行董 事、重庆梦马致新科技有限公司董事长、烟台阳光壹佰投资有限公司监事、科 甸技术（深圳）有限公司监事、辩证商务服务（北京）有限公司执行董事、人 保资本保险资产管理有限公司独立董 ...

江苏立华食品集团股份有限公司 2024 年度独立董事述职报告 各位股东及股东代表： 本人王志跃作为江苏立华食品集团股份有限公司（以下简称公司或本公 司）的独立董事，在任职期间严格按照《中华人民共和国公司法》《上市公司 独立董事管理办法》和《深圳证券交易所创业板股票上市规则》等法律、法规 以及《公司章程》《独立董事制度》等规定，积极参加公司历次董事会、股东 会，充分发挥独立董事的作用，切实维护公司和股东尤其是中小股东的利益。 现将 2024 年度履职情况报告如下： （一）出席公司董事会和股东会情况 2024 年，公司共召开 7 次董事会会议和 4 次股东会会议，本人出席会议情 况如下： | | | 出席董事会会议情况 | | | 出席股东大会会议情况 | | | --- | --- | --- | --- | --- | --- | --- | | 召开董事会 次数 | 出席方式 | 委托出席次数 | 缺席次数 | 是否连续两次未亲 自参加董事会会议 | 召开股东大会 次数 | 出席股东大会 次数 | | 7 | 现场或通讯 | 0 | 0 | 否 | 4 | 4 | | | | | 1 | | | | 202 ...

江苏立华食品集团股份有限公司 董事会关于独立董事独立性评估的专项意见 江苏立华食品集团股份有限公司（以下简称公司）董事会根据《上市公司 独立董事管理办法》《深圳证券交易所创业板股票上市规则》《深圳证券交易 所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等要求，并结 合独立董事出具的《独立董事独立性自查情况表》，对公司在任独立董事的独 立性情况进行了评估，并出具如下意见： 经核查，公司独立董事不存在任何妨碍其进行独立客观判断的关系，不存 在影响独立董事独立性的情况，符合《上市公司独立董事管理办法》《深圳证 券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律法规及《公司章程》中关于独立董事 的任职资格及独立性的要求。 江苏立华食品集团股份有限公司 董事会 2025 年 4 月 22 日 1 ...

江苏立华食品集团股份有限公司 2024 年度独立董事述职报告 各位股东及股东代表： 本人云昌智作为江苏立华食品集团股份有限公司（以下简称公司或本公 司）的独立董事，在任职期间严格按照《中华人民共和国公司法》《上市公司 独立董事管理办法》和《深圳证券交易所创业板股票上市规则》等法律、法规 以及《公司章程》《独立董事制度》等规定，积极参加公司历次董事会、股东 会，充分发挥独立董事的作用，切实维护公司和股东尤其是中小股东的利益。 现将 2024 年度履职情况报告如下： 一、独立董事基本情况 本人云昌智，1974 年出生，中国国籍，无永久境外居留权，北京大学涉外 经济法学博士，曾任贝克麦肯斯国际律师事务所高级顾问、权亚律师事务所高 级顾问、联想集团法务部高级商事法律顾问、博彦科技股份有限公司监事会主 席、集团副总裁、总法律顾问、信息安全事务总负责人、海南永旭新能源有限 公司副总经理兼法务总监、金元证券股份有限公司独立董事。现任中央财经大 学法学院访问教授、北京正源浩科技有限公司法律顾问。兼任新余飞年达投资 管理有限公司监事、北京厚象科技有限公司执行董事兼总经理、广东尚研电子 科技股份有限公司独立董事、广东格林精密部件 ...

Financial Performance - The company achieved a total revenue of 17.725 billion yuan in 2024, representing a year-on-year growth of 15.44%[3] - The company's operating revenue for 2024 reached RMB 17,724,875,417.76, an increase of 15.44% compared to RMB 15,354,096,858.27 in 2023[25] - The net profit attributable to shareholders for 2024 was RMB 1,520,963,179.35, a significant increase of 447.72% from a loss of RMB 437,409,219.32 in 2023[25] - Basic earnings per share for 2024 were RMB 1.8377, a recovery from a loss of RMB 0.5285 in 2023, marking an increase of 447.72%[25] - The cash flow from operating activities for 2024 was RMB 2,408,025,257.96, reflecting a growth of 66.02% compared to RMB 1,450,479,021.85 in 2023[25] - The company reported quarterly revenues of RMB 5,041,053,369.81 in Q4 2024, showing a consistent growth trend throughout the year[27] - The company has successfully recovered from previous losses, indicating a strong turnaround in financial performance and operational efficiency[25] Production and Sales - The number of listed quality meat chickens reached 516 million, an increase of 12.95% year-on-year; listed meat pigs totaled 1.298 million heads, up 51.8%; and listed meat geese reached 2.0963 million, growing by 21.73%[3] - The slaughtering capacity for meat chickens reached 120 million, with processed fresh chicken products exceeding 60 million, doubling year-on-year[4] - The company sold 516 million meat chickens in 2024, increasing its market share as the total national output was 3.334 billion[49] - The company sold 1.298 million pigs in 2024, reflecting a growth of 51.80% year-on-year[86] - The company sold 2.0963 million geese during the reporting period, establishing a leading position in the integrated goose farming business in China[63] - The company's core business, the yellow feathered chicken segment, saw a revenue increase of 8.01% to 14.531 billion RMB, accounting for 81.98% of total revenue[54] Research and Development - The company's R&D investment for 2024 was 140 million yuan, focusing on technological advancements and efficiency improvements in breeding[3] - The company invested 140.463 million yuan in R&D during the reporting period, with 25 intellectual property applications filed[79] - The company has developed a low-protein diet formula, reducing crude protein levels by 1-2% year-on-year, enhancing breeding efficiency[3] - The company has established a health management system that enhances animal health levels and improves market readiness[78] - The company has increased its R&D personnel to 403 in 2024, a rise of 12.57% from 358 in 2023, with a proportion of 5.05% of total employees[101] Market Strategy and Expansion - The company aims to extend its operations from breeding to food processing, becoming a comprehensive food supplier covering the entire industry chain[8] - The company plans to continue expanding its market presence and investing in new product development to sustain growth in the coming years[25] - The company is focusing on the development of pre-prepared dishes, aligning with national policies to enhance food safety and quality in the industry[38] - The company is actively expanding its market presence through technological innovation and collaboration with agricultural institutions[50] - The company plans to expand its market presence with new projects in Xuzhou and Shaoguan, aiming for a production capacity increase of 18% by the end of 2023[120] Financial Management and Investments - The company plans to distribute a cash dividend of 414 million yuan for 2024, with a total cash dividend rate of 43.53%[7] - The company reported a government subsidy of approximately ¥44.19 million in 2024, an increase from ¥41.98 million in 2023, and ¥30.88 million in 2022, indicating a consistent growth trend in government support[31] - The total investment amount for the reporting period was approximately ¥5.47 billion, representing a year-on-year increase of 10.19% compared to ¥4.97 billion in the previous year[110] - The company has established a database for the growth and development patterns of commercial geese, revising nutritional requirements for 10-week and 14-week old geese[100] - The company has committed to using surplus funds for daily operational expenses while ensuring that outstanding payments for fundraising projects will be settled from the fundraising account[123] Risk Management - The company faces risks related to product price fluctuations, which could impact profitability due to market supply and demand dynamics[138] - The company is exposed to raw material supply and price volatility risks, particularly for key feed ingredients like corn and soybean meal[139] - The company must manage risks associated with animal diseases that could affect production efficiency and market demand[141] - The company employs a combination of policy and commercial agricultural insurance to mitigate risks from natural disasters and animal diseases, ensuring asset and product safety[149] Governance and Compliance - The company has a governance structure with a shareholder meeting as the highest authority, a board of directors for decision-making, and a supervisory board for oversight[165] - The company emphasizes social responsibility and has issued a sustainable development report for 2024, to be disclosed in April 2025[161] - The company maintains transparent information disclosure practices, ensuring timely and accurate communication with investors[162] - The board of directors held a total of 7 meetings during the reporting period, with an average attendance of 2 in person and 5 via communication[181] Employee Management and Training - The company has a total of 7,975 employees, with 6,293 in production, 569 in sales, and 525 in technical roles[190] - The company plans to conduct over 380 professional training sessions in 2024, with more than 7,000 participants expected[192] - The company has established a training team of 59 internal trainers, conducting over 120 sessions in 2024[192] - The company emphasizes a diverse training approach, including internal and external training, to meet various employee learning needs[192]

Financial Performance - The company's revenue for Q1 2025 reached ¥4,086,417,957.77, an increase of 11.60% compared to ¥3,661,508,242.90 in the same period last year[5] - Net profit attributable to shareholders was ¥206,056,594.79, representing a significant increase of 157.47% from ¥80,031,532.61 year-on-year[5] - Basic and diluted earnings per share both increased to ¥0.2490, up 157.50% from ¥0.0967 in the same period last year[5] - Total operating revenue for the current period reached ¥4,086,417,957.77, an increase of 11.6% compared to ¥3,661,508,242.90 in the previous period[23] - Net profit for the current period was ¥202,598,497.25, significantly higher than ¥78,660,455.15 from the previous period, marking an increase of 157.9%[24] - The total comprehensive income for the period was ¥202,598,497.25, compared to ¥78,660,455.15 in the previous period, representing an increase of approximately 157.5%[25] Cash Flow - The net cash flow from operating activities improved by 77.78%, totaling ¥387,868,794.47 compared to ¥218,171,962.62 in the previous year[5] - Cash inflow from operating activities totaled ¥4,291,568,077.11, compared to ¥3,860,976,341.00 in the previous period, marking an increase of approximately 11.1%[27] - Cash outflow for purchasing goods and services was ¥3,333,834,310.60, compared to ¥3,195,436,769.82, which is an increase of about 4.3%[27] - Net cash flow from investing activities was -¥216,958,834.33, worsening from -¥55,127,044.61 in the previous period[28] - Cash inflow from financing activities was ¥1,253,000,000.00, up from ¥940,000,000.00, representing a growth of approximately 33.3%[28] - The ending cash and cash equivalents balance was ¥556,235,940.36, down from ¥774,895,706.04, indicating a decrease of about 28.2%[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥15,165,431,889.71, reflecting a 3.01% increase from ¥14,722,259,056.66 at the end of the previous year[5] - Current liabilities rose to ¥5,041,190,735.24, compared to ¥4,803,974,665.86, indicating an increase of 4.9%[21] - The company's total liabilities increased to ¥5,773,578,662.24 from ¥5,564,778,026.44, showing a growth of 3.8%[21] - The company's equity attributable to shareholders increased to ¥9,298,106,956.14 from ¥9,060,276,661.35, a rise of 2.6%[21] - The company's long-term borrowings decreased to ¥51,740,000.71 from ¥82,207,591.32, a reduction of 37.0%[21] Research and Development - Research and development expenses rose by 67.47% to ¥31,027,452.93, primarily due to increased investment in breeding[12] - Research and development expenses for the current period were ¥31,027,452.93, up from ¥18,527,339.07, reflecting a growth of 67.4%[24] Investment and Income - Investment income surged by 674.04% to ¥31,289,497.54, compared to a loss of ¥5,450,736.26 in the same period last year[12] - The company reported an investment income of ¥31,289,497.54, a significant recovery from a loss of ¥5,450,736.26 in the previous period[24] Shareholder Information - The total number of restricted shares at the end of the period was 208,828,261, down from 226,352,851, after 17,524,590 shares were released from restriction[17] - The company has a high concentration of ownership, with the top 10 shareholders holding significant stakes, including 157,500,000 shares held by Changzhou Benteng Animal Husbandry Technology Service Center[15] - The company’s major shareholder, Cheng Lili, holds 67,532,625 shares, representing a substantial portion of the total shares outstanding[15] - The company has a strategy to gradually release restricted shares, with 25% of the shares being released annually based on the previous year's holdings[17] Other Information - The company reported a significant increase in accounts receivable, which rose by 39.67% to ¥19,691,397.35, mainly due to increased slaughter receivables[10] - Cash and cash equivalents increased by 212.87% to ¥573,683,768.55, compared to ¥183,364,069.78 at the end of the previous year[10] - The company's trading financial assets decreased from ¥643,171,167.15 to ¥302,553,400.61, indicating a reduction of approximately 53%[19] - Accounts receivable increased from ¥14,098,166.16 to ¥19,691,397.35, reflecting a growth of about 39%[19] - Prepayments decreased significantly from ¥76,581,673.42 to ¥32,829,553.58, a decline of approximately 57%[19] - Other receivables showed a slight increase from ¥309,380,725.31 to ¥324,148,420.33, representing a growth of about 5%[19] - The company reported no net profit from merged entities prior to consolidation for both periods[25] - The first quarter report was not audited, as stated in the audit report[30]